Literature DB >> 28930284

Effects of Intranasal Oxytocin on the Blood Oxygenation Level-Dependent Signal in Food Motivation and Cognitive Control Pathways in Overweight and Obese Men.

Franziska Plessow1,2, Dean A Marengi1, Sylvia K Perry1, Julia M Felicione3, Rachel Franklin3, Tara M Holmes4, Laura M Holsen5,6, Nikolaos Makris6,7,8, Thilo Deckersbach3,6, Elizabeth A Lawson1,2.   

Abstract

Recent research indicates that the hypothalamic neuropeptide hormone oxytocin is a key central nervous system factor in the regulation of food intake and weight. However, the mechanisms underlying the anorexigenic effects of oxytocin in humans are unknown and critical to study to consider oxytocin as a neurohormonal weight loss treatment. We performed a randomized, double-blind, placebo-controlled crossover study with single-dose intranasal oxytocin (24 IU) in ten overweight or obese, otherwise healthy men. Following oxytocin/placebo administration, participants completed an established functional magnetic resonance imaging food motivation paradigm. We hypothesized that oxytocin would reduce the blood oxygenation level-dependent (BOLD) signal to high-calorie food vs non-food visual stimuli in the ventral tegmental area (VTA), the origin of the mesolimbic dopaminergic reward system. Following oxytocin administration, compared to placebo, participants showed bilateral VTA hypoactivation to high-calorie food stimuli. A secondary exploratory whole-brain analysis revealed hypoactivation in additional hedonic (orbitofrontal cortex, insula, globus pallidus, putamen, hippocampus, and amygdala) and homeostatic (hypothalamus) food motivation and hyperactivation in cognitive control (anterior cingulate and frontopolar cortex) brain regions following oxytocin administration vs placebo. Oxytocin administration reduces the BOLD signal in reward-related food motivation brain regions, providing a potential neurobiological mechanism for the anorexigenic oxytocin effects in humans. Furthermore, our data indicate that oxytocin administration reduces activation in homeostatic and increases activation in cognitive control brain regions critically involved in regulating food intake and resolving affective conflict, respectively. Future studies are required to link these changes in brain activation to oxytocin effects on food intake and weight.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28930284      PMCID: PMC5770767          DOI: 10.1038/npp.2017.226

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  48 in total

Review 1.  Dopaminergic-neuropeptide interactions in the social brain.

Authors:  David H Skuse; Louise Gallagher
Journal:  Trends Cogn Sci       Date:  2008-12-10       Impact factor: 20.229

2.  No laughing matter: intranasal oxytocin administration changes functional brain connectivity during exposure to infant laughter.

Authors:  Madelon M E Riem; Marinus H van IJzendoorn; Mattie Tops; Maarten A S Boksem; Serge A R B Rombouts; Marian J Bakermans-Kranenburg
Journal:  Neuropsychopharmacology       Date:  2011-12-21       Impact factor: 7.853

3.  Measurement of physical activity to assess health effects in free-living populations.

Authors:  R S Paffenbarger; S N Blair; I M Lee; R T Hyde
Journal:  Med Sci Sports Exerc       Date:  1993-01       Impact factor: 5.411

Review 4.  Relative reinforcing value of food and delayed reward discounting in obesity and disordered eating: A systematic review.

Authors:  Monika M K Stojek; James MacKillop
Journal:  Clin Psychol Rev       Date:  2017-04-21

5.  Inhibiting food reward: delay discounting, food reward sensitivity, and palatable food intake in overweight and obese women.

Authors:  Bradley M Appelhans; Kathleen Woolf; Sherry L Pagoto; Kristin L Schneider; Matthew C Whited; Rebecca Liebman
Journal:  Obesity (Silver Spring)       Date:  2011-04-07       Impact factor: 5.002

6.  The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger.

Authors:  A J Stunkard; S Messick
Journal:  J Psychosom Res       Date:  1985       Impact factor: 3.006

7.  Oxytocin reduces reward-driven food intake in humans.

Authors:  Volker Ott; Graham Finlayson; Hendrik Lehnert; Birte Heitmann; Markus Heinrichs; Jan Born; Manfred Hallschmid
Journal:  Diabetes       Date:  2013-07-08       Impact factor: 9.461

8.  Oxytocin reduces caloric intake in men.

Authors:  Elizabeth A Lawson; Dean A Marengi; Rebecca L DeSanti; Tara M Holmes; David A Schoenfeld; Christiane J Tolley
Journal:  Obesity (Silver Spring)       Date:  2015-04-10       Impact factor: 5.002

9.  Oxytocin administration suppresses hypothalamic activation in response to visual food cues.

Authors:  Agatha A van der Klaauw; Hisham Ziauddeen; Julia M Keogh; Elana Henning; Sekesai Dachi; Paul C Fletcher; I Sadaf Farooqi
Journal:  Sci Rep       Date:  2017-06-27       Impact factor: 4.379

Review 10.  Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Viktoria L Gloy; Matthias Briel; Deepak L Bhatt; Sangeeta R Kashyap; Philip R Schauer; Geltrude Mingrone; Heiner C Bucher; Alain J Nordmann
Journal:  BMJ       Date:  2013-10-22
View more
  17 in total

Review 1.  The Neuropeptide Hormone Oxytocin in Eating Disorders.

Authors:  Franziska Plessow; Kamryn T Eddy; Elizabeth A Lawson
Journal:  Curr Psychiatry Rep       Date:  2018-09-04       Impact factor: 5.285

Review 2.  Hypothalamic syndrome.

Authors:  Hermann L Müller; Maithé Tauber; Elizabeth A Lawson; Jale Özyurt; Brigitte Bison; Juan-Pedro Martinez-Barbera; Stephanie Puget; Thomas E Merchant; Hanneke M van Santen
Journal:  Nat Rev Dis Primers       Date:  2022-04-21       Impact factor: 52.329

3.  Utility of Downstream Biomarkers to Assess and Optimize Intranasal Delivery of Oxytocin.

Authors:  Megan DuBois; Angela Tseng; Sunday M Francis; Ann F Haynos; Carol B Peterson; Suma Jacob
Journal:  Pharmaceutics       Date:  2022-05-31       Impact factor: 6.525

Review 4.  Oxytocin as a potential pharmacological tool to combat obesity.

Authors:  Pawel K Olszewski; Emily E Noble; Luis Paiva; Yoichi Ueta; James E Blevins
Journal:  J Neuroendocrinol       Date:  2022-02-22       Impact factor: 3.870

5.  Effects of Chronic Oxytocin Administration and Diet Composition on Oxytocin and Vasopressin 1a Receptor Binding in the Rat Brain.

Authors:  Sara M Freeman; Julie Ngo; Bhavdeep Singh; Megan Masnaghetti; Karen L Bales; James E Blevins
Journal:  Neuroscience       Date:  2018-07-31       Impact factor: 3.590

6.  Intranasal oxytocin reduces weight gain in diet-induced obese prairie voles.

Authors:  Adele M Seelke; Maya A Rhine; Konterri Khun; Amira N Shweyk; Alexandria M Scott; Jessica M Bond; James L Graham; Peter J Havel; Tami Wolden-Hanson; Karen L Bales; James E Blevins
Journal:  Physiol Behav       Date:  2018-08-23

Review 7.  Metabolic Effects of Oxytocin.

Authors:  Shana E McCormack; James E Blevins; Elizabeth A Lawson
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

Review 8.  The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis.

Authors:  Elizabeth A Lawson; Pawel K Olszewski; Aron Weller; James E Blevins
Journal:  J Neuroendocrinol       Date:  2019-11-28       Impact factor: 3.627

9.  Oxytocin Administration Increases Proactive Control in Men with Overweight or Obesity: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.

Authors:  Franziska Plessow; Dean A Marengi; Sylvia K Perry; Elizabeth A Lawson
Journal:  Obesity (Silver Spring)       Date:  2020-11-22       Impact factor: 5.002

10.  Oxytocin reduces the functional connectivity between brain regions involved in eating behavior in men with overweight and obesity.

Authors:  Liya Kerem; Nouchine Hadjikhani; Laura Holsen; Elizabeth A Lawson; Franziska Plessow
Journal:  Int J Obes (Lond)       Date:  2019-11-18       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.